Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Research

Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone

Irfan A. Dhalla, Muhammad M. Mamdani, Marco L.A. Sivilotti, Alex Kopp, Omar Qureshi and David N. Juurlink
CMAJ December 08, 2009 181 (12) 891-896; DOI: https://doi.org/10.1503/cmaj.090784
Irfan A. Dhalla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad M. Mamdani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco L.A. Sivilotti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Kopp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omar Qureshi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David N. Juurlink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 181 no. 12 891-896
DOI 
https://doi.org/10.1503/cmaj.090784
PubMed 
19969578
History 
  • Published online December 7, 2009.

Article Versions

  • Latest version (December 7, 2009 - 08:20).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009

Author Information

  1. Irfan A. Dhalla, MD MSc,
  2. Muhammad M. Mamdani, PharmD MPH,
  3. Marco L.A. Sivilotti, MD MSc,
  4. Alex Kopp, BA,
  5. Omar Qureshi, MD,
  6. David N. Juurlink, MD PhD
  1. From the Departments of Medicine (Dhalla, Juurlink) and of Health Policy, Management and Evaluation (Dhalla), University of Toronto, Toronto, Ont.; the Department of Medicine and the Keenan Research Centre of the Li Ka Shing Knowledge Institute (Dhalla, Mamdani), St. Michael’s Hospital, Toronto, Ont.; the Institute for Clinical Evaluative Sciences (Mamdani, Kopp, Juurlink), Toronto, Ont.; the Departments of Emergency Medicine and of Pharmacology and Toxicology (Sivilotti), Queen’s University, Kingston, Ont.; the Department of Family Medicine (Qureshi), State University of New York at Buffalo, Buffalo, USA; Sunnybrook Health Sciences Centre (Juurlink), Toronto, Ont.; and the Faculty of Medicine (Mandani), King Saud University, Riyadh, Saudi Arabia
  1. Correspondence to:
    Dr. Irfan A. Dhalla, Department of Medicine, St. Michael’s Hospital, 30 Bond St., Toronto ON M5B 1W8; dhallai{at}smh.toronto.on.ca
View Full Text

Statistics from Altmetric.com

Usage statistics: December 2009 to February 2023

AbstractFullPdf
Dec 2009133412901332
Jan 2010187399306
Feb 2010215161172
Mar 2010112125158
Apr 2010638093
May 20104112792
Jun 20104912641
Jul 20105310546
Aug 2010358943
Sep 20104110568
Oct 20105811485
Nov 2010678985
Dec 2010556553
Jan 2011408887
Feb 2011799293
Mar 20118112798
Apr 2011637054
May 2011678673
Jun 2011647472
Jul 2011815869
Aug 20111015983
Sep 2011887893
Oct 20111297485
Nov 201111410268
Dec 2011718336
Jan 20129210062
Feb 201221112186
Mar 2012220173128
Apr 201213114285
May 201211513270
Jun 20121057049
Jul 2012857268
Aug 2012775143
Sep 20121099254
Oct 20121178881
Nov 201218385112
Dec 20121687949
Jan 201321614366
Feb 20131606359
Mar 20131326048
Apr 20131728984
May 20131315062
Jun 2013676128
Jul 20131198524
Aug 2013867524
Sep 201310112649
Oct 2013956028
Nov 20131208336
Dec 2013694131
Jan 2014795326
Feb 2014914636
Mar 20141206150
Apr 20141022122
May 20141112735
Jun 2014782029
Jul 2014803753
Aug 20148123750
Sep 2014879629
Oct 20141005450
Nov 20141446044
Dec 20141175228
Jan 2015985225
Feb 2015704769
Mar 2015565531
Apr 2015864925
May 2015864021
Jun 2015776250
Jul 2015915024
Aug 20151406051
Sep 2015982427
Oct 20151275132
Nov 2015116114204
Dec 201518312156
Jan 201618714968
Feb 201616719671
Mar 2016222209143
Apr 201610317665
May 20165217642
Jun 20165416630
Jul 201612011930
Aug 20165918918
Sep 20167023344
Oct 20169030949
Nov 20166529225
Dec 20165526620
Jan 20179324029
Feb 201710724831
Mar 201716821356
Apr 201711423319
May 20171076830
Jun 2017765914
Jul 20178014215
Aug 20178422029
Sep 20178716033
Oct 20171169950
Nov 201722323835
Dec 20174429116
Jan 20184826615
Feb 201810926735
Mar 201811615730
Apr 20189810842
May 20187214919
Jun 20186963717
Jul 20184413236
Aug 20182911617
Sep 20187014320
Oct 201811324532
Nov 201812524846
Dec 20186016449
Jan 20197521331
Feb 20195117831
Mar 20191319231
Apr 20192615424
May 20197216423
Jun 201941208
Jul 2019814528
Aug 2019022421
Sep 2019324325
Oct 20194819359
Nov 20192424576
Dec 20191015222
Jan 20202511732
Feb 20202420131
Mar 20202532444
Apr 20201115554
May 20203423654
Jun 2020154243
Jul 2020165535
Aug 2020309837
Sep 20201911779
Oct 20201712764
Nov 20202414361
Dec 20203015757
Jan 2021168856
Feb 2021145228
Mar 2021218924
Apr 2021208930
May 20213010935
Jun 202199724
Jul 2021812637
Aug 2021196526
Sep 2021118823
Oct 2021207957
Nov 2021156045
Dec 2021199235
Jan 2022146821
Feb 2022166818
Mar 2022299324
Apr 2022208721
May 20221110428
Jun 20229010931
Jul 2022128523
Aug 2022159120
Sep 20221513138
Oct 20222811039
Nov 20221211627
Dec 2022127715
Jan 20231111725
Feb 20231167

Cited By...

  • 316 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 181 (12)
CMAJ
Vol. 181, Issue 12
8 Dec 2009
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone
Irfan A. Dhalla, Muhammad M. Mamdani, Marco L.A. Sivilotti, Alex Kopp, Omar Qureshi, David N. Juurlink
CMAJ Dec 2009, 181 (12) 891-896; DOI: 10.1503/cmaj.090784

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone
Irfan A. Dhalla, Muhammad M. Mamdani, Marco L.A. Sivilotti, Alex Kopp, Omar Qureshi, David N. Juurlink
CMAJ Dec 2009, 181 (12) 891-896; DOI: 10.1503/cmaj.090784
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Interpretation
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • Deaths related to the use of prescription opioids
  • PubMed
  • Google Scholar

Cited By...

  • Cohort profile: development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada
  • Optimizing opioid prescriptions after laparoscopic appendectomy and cholecystectomy
  • Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis
  • Influence of opioid prescribing standards on health outcomes among patients with long-term opioid use: a longitudinal cohort study
  • Patterns of opioid use (codeine, morphine or meperidine) in the Canadian population over time: analysis of the Longitudinal National Population Health Survey 1994-2011
  • Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal
  • Exponential growth of the USA overdose epidemic
  • Relation between opioid-related harms and socioeconomic inequalities in Ontario: a population-based descriptive study
  • Quantity of opioids consumed following an emergency department visit for acute pain: a Canadian prospective cohort study
  • Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
  • Les nouvelles recommandations sur les opioides nuiront-elles plus quelles aideront les gens?: Non
  • Refutation : Les nouvelles recommandations sur les opioides nuiront-elles plus quelles aideront les gens?: Non
  • Will the new opioid guidelines harm more people than they help?: No
  • Rebuttal: Will the new opioid guidelines harm more people than they help?: No
  • Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
  • Availability of naloxone in Canadian pharmacies:a population-based survey
  • Prise en charge des troubles de consommation dopioides en premiere ligne: Abstinence, methadone ou buprenorphine-naloxone?
  • Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
  • Effective Canadian policy to reduce harms from prescription opioids: learning from past failures
  • National opioid crisis
  • Trends and sex differences in prescription opioid deaths in British Columbia, Canada
  • Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches
  • Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths
  • Tamper-resistant drugs cannot solve the opioid crisis
  • Can naloxone prescription and overdose training for opioid users work in family practice?: Perspectives of family physicians
  • Retrospective analysis of trends in dispensing long-acting non-tamper-resistant oxycodone near the Canada-United States border
  • Neonatal opioid withdrawal and antenatal opioid prescribing
  • Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: Evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program
  • The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
  • Incidence of narcotic abuse during pregnancy in northwestern Ontario: Three-year prospective cohort study
  • Trends in high-dose opioid prescribing in Canada
  • Questionable content of an industry-supported medical school lecture series: a case study
  • Patient therapeutic education: Placing the patient at the centre of the WHO analgesic ladder
  • Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis
  • Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study
  • A Call For Evidence-Based Medical Treatment Of Opioid Dependence In The United States And Canada
  • The right drug for the right patient: Caring for our patients while minimizing prescription drug misuse
  • Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing
  • Opioids for chronic non-cancer pain
  • Dependance aux opioides
  • Opioid dependence
  • Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse
  • Don't tamper with oxycodone
  • Opioids for osteoarthritis pain: benefits and risks
  • Pratiques optimales de prescription: Que peuvent faire les medecins?
  • Achieving optimal prescribing: What can physicians do?
  • Controler la douleur et reduire l'usage abusif d'opioides: Questions d'ethique
  • Controlling pain and reducing misuse of opioids: Ethical considerations
  • Prescription opioid use and misuse: Piloting an educational strategy for rural primary care physicians
  • Lessons from the past
  • Opioids and chronic pain
  • Opioids versus nonsteroidal anti-inflammatory drugs in noncancer pain
  • Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 1: general population
  • Usage abusif des opioides d'ordonnance: Quel est le vrai probleme et comment le reglons-nous?
  • Lignes directrices canadiennes sur l'utilisation securitaire et efficace des opioides pour la douleur chronique non cancereuse: Resume clinique pour les medecins de famille. Partie 2: populations particulieres
  • Prescription opioid abuse: What is the real problem and how do we fix it?
  • Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 2: special populations
  • Lignes directrices canadiennes sur l'utilisation securitaire et efficace des opioides pour la douleur chronique non cancereuse: Resume clinique pour les medecins de famille. Partie 1: population en general
  • Pharmacists' experiences with dispensing opioids: Provincial survey
  • Facing up to the prescription opioid crisis
  • Increasing deaths involving oxycodone, Victoria, Australia, 2000-09
  • We can't feel their pain, but we can understand their fears.
  • Treating patients versus numbers
  • Response
  • Survey of Ontario primary care physicians' experiences with opioid prescribing
  • Chronic noncancer pain: Characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic
  • Miconazole Oral Gel Increases Exposure to Oral Oxycodone by Inhibition of CYP2D6 and CYP3A4
  • Opioides, douleur et personnalite: Recit d'un medecin remplacant
  • Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario
  • Opioids, pain, and personality: The story of a substitute physician
  • Has the time come to phase out codeine?
  • High cost, dubious benefit
  • Where are the drugs from?
  • Google Scholar

More in this TOC Section

  • Hospital factors associated with maternal and neonatal outcomes of deliveries to patients with a previous cesarean delivery: an ecological study
  • Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study
  • Association between virtual primary care and emergency department use during the first year of the COVID-19 pandemic in Ontario, Canada
Show more Research

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire